Streetbeat News

Products Services

INSM

Insmed Incorporated (NASDAQ:INSM) presented additional positive data from its ASPEN study on brensocatib at the 7th World Bronchiectasis Conference. The study showed significantly less decline in lung function for patients taking brensocatib compared to a placebo.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 1:04 pm

RIOT

Riot Platforms, Inc. (NASDAQ:RIOT) announced its June 2024 operations update, revealing the production of 255 Bitcoin and achieving a deployed hash rate of 22.0 EH/s, surpassing its Q2 2024 target. The company anticipates reaching a total self-mining hash rate capacity of 31 EH/s by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 1:03 pm

ARTL

Artelo Biosciences presented data from preclinical studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium. The data showcased the potential therapeutic benefits of ART12.11.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 1:02 pm

SLB

TTE

SLB has been awarded a contract by TotalEnergies for a 13-well subsea production system in the Kaminho Project offshore Angola. The project will be developed in two phases for the Cameia and Golfinho discoveries.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 1:01 pm

AMIX

Autonomix Medical's Chief Medical Officer, Dr. Robert Schwartz, discussed preliminary positive results from the first five 'lead-in' patients in the company's ongoing human clinical trial for pancreatic cancer pain. The results were reviewed in a virtual investor segment titled 'What This Means.'

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 1:00 pm

RIVN

Rivian Automotive Inc (NASDAQ:RIVN) shares are experiencing volatility following reports that the company has no plans to produce vehicles with Volkswagen under their recently announced joint venture. The joint venture will focus on creating next-generation software-defined vehicle platforms, with Volkswagen investing $1 billion initially and an additional $4 billion over time.

Portfolio Pulse from Adam Eckert

July 03, 2024 | 1:00 pm

MAXN

Maxeon Solar Technologies (NASDAQ:MAXN) shares surged by 11% after the company was granted a U.S. patent for a protection coating for solar cell wafers. This innovation could enhance the efficiency, durability, or cost-effectiveness of their solar cells, providing a competitive edge and potential revenue boosts through licensing or partnerships.

Portfolio Pulse from Henry Khederian

July 03, 2024 | 12:57 pm

TSLA

Ben Smith, co-founder and editor-in-chief of Semafor, commented on CNBC's 'Last Call' that Tesla's sales are declining, potentially due to CEO Elon Musk's political stance. Despite being an amazing company, Tesla is not selling as many cars as it used to, and competitors are faring better in the EV industry. Musk's controversial social media posts and political leanings may be driving some buyers away.

Portfolio Pulse from Benzinga Neuro

July 03, 2024 | 12:57 pm

REGN

SNY

The European Medicines Agency (EMA) has approved Sanofi and Regeneron's Dupixent for use in treating chronic obstructive pulmonary disease (COPD) in adults, marking the first approval of its kind globally. This approval is based on positive results from the phase 3 BOREAS and NOTUS studies. The FDA has requested additional data before making a decision on Dupixent's approval for COPD in the US.

Portfolio Pulse from Vandana Singh

July 03, 2024 | 12:55 pm

ICU

SeaStar Medical shares are trading higher after the company finalized FDA labeling requirements for QUELIMMUNE.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 12:49 pm